Thomas Benjamin Karasic (Thomas B Karasic, Thomas Karasic)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 22

Top Topics

Metastatic Colorectal Cancer

Top Venues

Cancer research communications

Nature communications

Cancer medicine

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy J Brown, Phyllis A Gimotty, Ronac Mamtani, Thomas Benjamin Karasic, Yu-Xiao Yang
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. JCO clinical cancer informatics 8 (2024)
Jacob E Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M Pfeiffer, Jaclyn P Lyman, Lacey J Padrón, Deena M Maurer, Jia Xin Yu, Christine N Spencer, Pier Federico Gherardini, Diane M Da Silva, Theresa M LaVallee, Charles Abbott, Richard O Chen, Sean Michael Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Benjamin Karasic, Charles Schneider, Peter J O'Dwyer, Ursina Teitelbaum, Kim A Reiss, Osama E Rahma, George A Fisher, Andrew H Ko, Zev A Wainberg, Robert A Wolff, Eileen M O'Reilly, Mark H O'Hara, Christopher R Cabanski, Robert A Anders, Erica L Carpenter
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma. Nature communications 15 (1) (2024)
Timothy J Brown, Phyllis A Gimotty, Ronac Mamtani, Thomas Benjamin Karasic, Yu-Xiao Yang
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. JCO clinical cancer informatics 8 (2024)
Jacob E Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M Pfeiffer, Jaclyn P Lyman, Lacey J Padrón, Deena M Maurer, Jia Xin Yu, Christine N Spencer, Pier Federico Gherardini, Diane M Da Silva, Theresa M LaVallee, Charles Abbott, Richard O Chen, Sean Michael Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Benjamin Karasic, Charles Schneider, Peter J O'Dwyer, Ursina Teitelbaum, Kim A Reiss, Osama E Rahma, George A Fisher, Andrew H Ko, Zev A Wainberg, Robert A Wolff, Eileen M O'Reilly, Mark H O'Hara, Christopher R Cabanski, Robert A Anders, Erica L Carpenter
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma. Nature communications 15 (1) (2024)
Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas Benjamin Karasic, Oxana V Crysler, Pamela N Munster, Meredith A McKean, Leisha A Emens, Yvonne M Saenger, Yasser Ged, Robert Stagg, Steven Smith, Chan C Whiting, Anne Moon, Peppi Prasit, Yonchu Jenkins, Nathan Standifer, Thomas W Dubensky, Sam H Whiting, Susanna V Ulahannan
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors. Cancer research communications 4 (4) (2024)
Jacob E Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M Pfeiffer, Jaclyn P Lyman, Lacey J Padrón, Deena M Maurer, Jia Xin Yu, Christine N Spencer, Pier Federico Gherardini, Diane M Da Silva, Theresa M LaVallee, Charles Abbott, Richard O Chen, Sean Michael Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Benjamin Karasic, Charles Schneider, Peter J O'Dwyer, Ursina Teitelbaum, Kim A Reiss, Osama E Rahma, George A Fisher, Andrew H Ko, Zev A Wainberg, Robert A Wolff, Eileen M O'Reilly, Mark H O'Hara, Christopher R Cabanski, Robert A Anders, Erica L Carpenter
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma. Nature communications 15 (1) (2024)
Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas Benjamin Karasic, Oxana V Crysler, Pamela N Munster, Meredith A McKean, Leisha A Emens, Yvonne M Saenger, Yasser Ged, Robert Stagg, Steven Smith, Chan C Whiting, Anne Moon, Peppi Prasit, Yonchu Jenkins, Nathan Standifer, Thomas W Dubensky, Sam H Whiting, Susanna V Ulahannan
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors. Cancer research communications 4 (4) (2024)
Jacob E Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M Pfeiffer, Jaclyn P Lyman, Lacey J Padrón, Deena M Maurer, Jia Xin Yu, Christine N Spencer, Pier Federico Gherardini, Diane M Da Silva, Theresa M LaVallee, Charles Abbott, Richard O Chen, Sean Michael Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Benjamin Karasic, Charles Schneider, Peter J O'Dwyer, Ursina Teitelbaum, Kim A Reiss, Osama E Rahma, George A Fisher, Andrew H Ko, Zev A Wainberg, Robert A Wolff, Eileen M O'Reilly, Mark H O'Hara, Christopher R Cabanski, Robert A Anders, Erica L Carpenter
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma. Nature communications 15 (1) (2024)
Jacob E Till, Lee McDaniel, Changgee Chang, Qi Long, Shannon M Pfeiffer, Jaclyn P Lyman, Lacey J Padrón, Deena M Maurer, Jia Xin Yu, Christine N Spencer, Pier Federico Gherardini, Diane M Da Silva, Theresa M LaVallee, Charles Abbott, Richard O Chen, Sean Michael Boyle, Neha Bhagwat, Samuele Cannas, Hersh Sagreiya, Wenrui Li, Stephanie S Yee, Aseel Abdalla, Zhuoyang Wang, Melinda Yin, Dominique Ballinger, Paul Wissel, Jennifer Eads, Thomas Benjamin Karasic, Charles Schneider, Peter J O'Dwyer, Ursina Teitelbaum, Kim A Reiss, Osama E Rahma, George A Fisher, Andrew H Ko, Zev A Wainberg, Robert A Wolff, Eileen M O'Reilly, Mark H O'Hara, Christopher R Cabanski, Robert A Anders, Erica L Carpenter
Circulating KRAS G12D but not G12V is associated with survival in metastatic pancreatic ductal adenocarcinoma. Nature communications 15 (1) (2024)
Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas Benjamin Karasic, Oxana V Crysler, Pamela N Munster, Meredith A McKean, Leisha A Emens, Yvonne M Saenger, Yasser Ged, Robert Stagg, Steven Smith, Chan C Whiting, Anne Moon, Peppi Prasit, Yonchu Jenkins, Nathan Standifer, Thomas W Dubensky, Sam H Whiting, Susanna V Ulahannan
First-in-Human Phase I Trial of TPST-1120, an inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors. Cancer research communications (2024)
Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas Benjamin Karasic, Oxana V Crysler, Pamela N Munster, Meredith A McKean, Leisha A Emens, Yvonne M Saenger, Yasser Ged, Robert Stagg, Steven Smith, Chan C Whiting, Anne Moon, Peppi Prasit, Yonchu Jenkins, Nathan Standifer, Thomas W Dubensky, Sam H Whiting, Susanna V Ulahannan
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors. Cancer research communications 4 (4) (2024)
Mark Yarchoan, John D Powderly, Bruno R Bastos, Thomas Benjamin Karasic, Oxana V Crysler, Pamela N Munster, Meredith A McKean, Leisha A Emens, Yvonne M Saenger, Yasser Ged, Robert Stagg, Steven Smith, Chan C Whiting, Anne Moon, Peppi Prasit, Yonchu Jenkins, Nathan Standifer, Thomas W Dubensky, Sam H Whiting, Susanna V Ulahannan
First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors. Cancer research communications 4 (4) (2024)
Jayesh Desai, Guzman Alonso, Se Hyun Kim, Andres Cervantes, Thomas Benjamin Karasic, Laura Medina, Einat Shacham-Shmueli, Rasha Cosman, Alejandro Falcón Gonzalez, Eelke Gort, Tormod Kyrre Guren, Erminia Massarelli, Wilson H Miller, Luis Paz-Ares, Hans Prenen, Alessio Amatu, Chiara Cremolini, Tae Won Kim, Victor Moreno, Sai-Hong Ignatius Ou, Alessandro Passardi, Adrian Sacher, Armando Santoro, Rafal Stec, Susanna Ulahannan, Kathryn C Arbour, Patricia M LoRusso, Jia Luo, Manish R Patel, Yoonha Choi, Zhen Shi, Sandhya Mandlekar, Mark T Lin, Stephanie Royer-Joo, Julie Chang, Tomi Jun, Neekesh V Dharia, Jennifer L Schutzman, null null, Sae-Won Han
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial. Nature medicine (2023)
Thomas Benjamin Karasic, Jennifer R Eads, Lipika Goyal
Precision Medicine and Immunotherapy Have Arrived for Cholangiocarcinoma: An Overview of Recent Approvals and Ongoing Clinical Trials. JCO precision oncology 7 (2023)
Timothy J Brown, Arielle Yablonovitch, Jacob E Till, Jennifer Yen, Lesli A Kiedrowski, Ryan Hood, Mark H O'Hara, Ursina Teitelbaum, Thomas Benjamin Karasic, Charles Schneider, Erica L Carpenter, Katherine L Nathanson, Susan M Domchek, Kim A Reiss
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Timothy J Brown, Ronac Mamtani, Phyllis A Gimotty, Thomas Benjamin Karasic, Yu-Xiao Yang
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis. Journal of cancer research and clinical oncology (2023)
William J Chapin, Wei-Ting Hwang, Thomas Benjamin Karasic, Anne Marie McCarthy, David E Kaplan
Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis. Cancer medicine (2022)
Thomas Benjamin Karasic, Timothy J Brown, Charles Schneider, Ursina R Teitelbaum, Kim A Reiss, Tara C Mitchell, Ryan C Massa, Mark H O'Hara, Lisa DiCicco, Luis Garcia-Marcano, Ravi K Amaravadi, Peter J O'Dwyer
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer. The oncologist 27 (9) (2022)
Kim A Reiss, Rosemarie Mick, Mark H O'Hara, Ursina Teitelbaum, Thomas Benjamin Karasic, Charles Schneider, Stacy Cowden, Traci Southwell, Janae Romeo, Natallia Izgur, Zain M Hannan, Rashmi Tondon, Katherine L Nathanson, Robert H Vonderheide, Max M Wattenberg, Gregory Beatty, Susan M Domchek
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Alexandra D Dreyfuss, Andrew R Barsky, E Paul Wileyto, Jennifer R Eads, John C Kucharczuk, Noel N Williams, Thomas Benjamin Karasic, James M Metz, Edgar Ben-Josef, John P Plastaras, Andrzej P Wojcieszynski
The efficacy and safety of definitive concurrent chemoradiotherapy for non-operable esophageal cancer. Cancer medicine 10 (4) (2021)
Thomas Benjamin Karasic, E Gabriela Chiorean, Said M Sebti, Peter J O'Dwyer
A Phase I Study of GGTI-2418 (Geranylgeranyl Transferase I Inhibitor) in Patients with Advanced Solid Tumors. Targeted oncology 14 (5) (2020)
Thomas Benjamin Karasic, Mark H O'Hara, Ursina R Teitelbaum, Nevena Damjanov, Bruce J Giantonio, Tracy S d'Entremont, Maryann Gallagher, Paul J Zhang, Peter J O'Dwyer
Phase II Trial of Palbociclib in Patients with Advanced Esophageal or Gastric Cancer. The oncologist 25 (12) (2020)